Aromatase Inhibitor Benefit Continues After End of Treatment
Even after the end of treatment, anastrozole (Arimidex), an aromatase inhibitor, outperforms tamoxifen in women with hormone-receptor-positive early breast cancer, a researcher said here.<?XML:NAMESPACE PREFIX = O /><O:P></O:P>
<O:P></O:P> <O:P>To read full article:</O:P> <O:P>http://www.medpagetoday.com/MeetingC...eeting/tb/7707</O:P> |
All times are GMT -7. The time now is 03:22 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021